- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04337320
Maternal And Neonatal Outcome of Pregnant Patients With COVID-19 in Istanbul, Turkey: A Single-Center, Retrospective, Descriptive Study
Maternal And Neonatal Outcome of Pregnant Patients With COVID-19
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
İ̇stanbul
-
Istanbul, İ̇stanbul, Turkey, 34000
- Pinar Yalcin Bahat
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- from covid 19 positive mothers
- newborn mothers had not other condition or illness
Exclusion Criteria:
- from covid 19 negative mothers
- childs
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Retrospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Evaluation of apgar status of newborns from covid 19 positive mothers
Time Frame: 2 months
|
The Apgar score is looked after at 1 and 5 minutes after birth, if the baby's Apgar score is lower than 7, it is repeated every 5 minutes until 20 minutes. Parameters examined in Apgar score Muscle tone, Heart rate, Reflexes, Skin color, Respiration. In the Apgar score, the baby is evaluated and scores are collected. 7 - 10: The baby is normal. 4 - 6: They usually recover with respiratory support. 0 - 3: Urgent intervention and resuscitation is needed. The low Apgar score in the 1st minute usually returns to normal in the 5th minute with support. Despite the intervention, the Apgar scores of 5 and less at 5 and 10 minutes are associated with an increased risk of mortality and cerebral palsy. |
2 months
|
Collaborators and Investigators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- covid19pregnancynewborn
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
-
Erasmus Medical CenterUniversity Medical Center Groningen; Academisch Medisch Centrum - Universiteit... and other collaboratorsRecruiting
Clinical Trials on newborns from covid 19 positive mothers
-
Hasanuddin UniversityChulalongkorn UniversityCompleted
-
University of Campania "Luigi Vanvitelli"UnknownCovid19 | Placenta Diseases | Preterm Birth | Miscarriage | SARS-CoV Infection | Obstetric ComplicationItaly
-
University of AberdeenCompletedCovid19 | Pulmonary EmbolismUnited Kingdom
-
Kanuni Sultan Suleyman Training and Research HospitalAyşegül Bestel; İbrahim Polat; Merve Aldıkaçtıoğlu TalmaçCompletedDepression, Postpartum | Anxiety | COVIDTurkey
-
Inova Health Care ServicesCompletedPregnancy Related | Corona Virus InfectionUnited States
-
Hamid Al-Essa Organ Transplant CenterMinistry of Health, KuwaitCompletedCovid19 | Risk Factor, Cardiovascular | Kidney Transplant Infection | Outcome, Fatal | Immunosuppression | Graft FailureKuwait
-
Fundacion Arturo Lopez PerezConfederación de la Producción y del Comercio (CPC); Bolsa de SantiagoUnknownCancer Patients | COVID-19 Infection | General PopulationChile
-
Medical University of GrazLagos State University; Walter Sisulu University; Management Sciences for Health and other collaboratorsEnrolling by invitationCovid19 | Hiv | ARTNigeria, South Africa
-
Helsinki University Central HospitalFinnish Red Cross Blood ServiceActive, not recruiting